SEC Form 4 · accession 0001209191-19-010172
Replimune Group, Inc. · REPL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atlas Venture Fund X, L.P.
10% Owner
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001737953
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 12, 2019 | J | 631,073 | $0.00 | D | 3,822,313 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represent a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund X, L.P. to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted in accordance with Rule 10b5-1 on August 22, 2018.